Involvement of miRNA in erythroid differentiation

Epigenomics

Volumn 4, Issue 1, 2012, Pages 51-65

  Bianchi, Nicoletta ^a   Zuccato, Cristina ^a,b   Finotti, Alessia ^a   Lampronti, Ilaria ^a   Borgatti, Monica ^a   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Associazione Veneta per la Lotta Alla Talassemia   (Italy)

Author keywords

thalassemia; erythroid differentiation; globin genes; HbF; miRNA

Indexed keywords

GAMMA GLOBIN; HEMOGLOBIN; MESSENGER RNA; MICRORNA; UNTRANSLATED RNA;

CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; EMBRYONIC STEM CELL; ERYTHROID CELL; GENE EXPRESSION REGULATION; HEMATOLOGIC DISEASE; HEMOGLOBIN SYNTHESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA DEGRADATION; TRANSLATION REGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; ERYTHROID CELLS; GENE EXPRESSION REGULATION; GLOBINS; HUMANS; MICRORNAS; MODELS, ANIMAL;

EID: 84857303993     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.11.104     Document Type: Review

References (82)

1. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531 (2010).
2. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucl. Acids Res. 39, 152-157 (2010).
3. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610 (2010).
4. Sontheimer EJ, Carthew RW. Silence from within: endogenous siRNAs and miRNAs. Cell 122, 9-12 (2005). (Pubitemid 40977934)
5. Subramanian S, Steer CJ. microRNAs as gatekeepers of apoptosis. J. Cell Physiol. 223, 89-98 (2010).
6. Wang F, Yu J, Yang GH, Wang XS, Zhang JW. Regulation of erythroid differentiation by miR-376a and its targets. Cell Res. 21(8), 1196-1209 (2011).
7. Alvarez-Garcia I, Miska EA. microRNA functions in animal development and human disease. Development 132, 4653-4662 (2005). (Pubitemid 41685276)
8. Taccioli C, Fabbri E, Visone R et al. UCbase & miRfunc: a database of ultraconserved sequences and microRNA function. Nucl. Acids Res. 37(Suppl. 1), D41-D48 (2009).
9. Bracken CP, Szubert JM, Mercer TR et al. Global analysis of the mammalian RNA degradome reveals widespread miRNA-dependent and miRNA-independent endonucleolytic cleavage. Nucl. Acids Res. 39(13), 5658-5668 (2011).
10. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 12, 99-110 (2011).
11. van Rooij E. The art of microRNA research. Circ. Res. Rev. 108(2), 219-234 (2011).
12. Huang Y, Zou Q, Song H et al. A study of miRNAs targets prediction and experimental validation. Prot. Cell 1(11), 979-986 (2010).
13. Bueno MJ, Malumbres M. microRNAs and the cell cycle. Biochim. Biophys. Acta 1812(5), 592-601 (2011).
14. Bayarsaihan D. Epigenetic mechanisms in inflammation. J. Dent. Res. Rev. 90(1), 9-17 (2011).
15. Zhang W, Dolan ME. The emerging role of microRNAs in drug responses. Curr. Opin. Mol. Ther. Rev. 12(6), 695-702 (2010).
16. Salminen A, Ojala J, Kaarniranta K. Apoptosis and aging: increased resistance to apoptosis enhances the aging process. Cell Mol. Life Sci. Rev. (6), 1021-1031 (2011).
17. Metallo CM, Azarin SM, Ji L, de Pablo JJ, Palecek SP. Engineering tissue from human embryonic stem cells. J. Cell Mol. Med. 12(3), 709-729 (2008).
18. Huang X, Gschweng E, Van Handel B, Cheng D, Mikkola HK, Witte ON. Regulated expression of microRNAs-126/126.* inhibits erythropoiesis from human embryonic stem cells. Blood 117(7), 2157-2165 (2011).
19. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45, 321-334 (1975).
20. Mikami M, Sadahira Y, Haga A, Otsuki T, Wada H, Sugihara T. Hypoxia-inducible factor-1 drives the motility of the erythroid progenitor cell line, UT-7/Epo, via autocrine motility factor. Exp. Hematol. 33(5), 531-541 (2005). (Pubitemid 40592169)
21. Sangokoya C, Telen MJ, Chi JT. microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Blood 116(20), 4338-4348 (2010).
22. Yang GH, Wang F, Yu J, Wang XS, Yuan JY, Zhang JW. microRNAs are involved in erythroid differentiation control. J. Cell Biochem. 107(3), 548-556 (2009).
23. Bruchova-Votavova H, Yoon D, Prchal JT. miR-451 enhances erythroid differentiation in K562 cells. Leuk. Lymphoma 51(4), 686-693 (2010).
24. Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R. Expression of miR-210 during erythroid differentiation and induction of g-globin gene expression. BMB Rep. 42(8), 493-499 (2009).
25. Gambari R, Fibach E. Medicinal chemistry of fetal hemoglobin inducers for treatment of b-thalassemia. Curr. Med. Chem. Rev. 14(2), 199-212 (2007). (Pubitemid 46043915)
26. Rutherford TR, Clegg JB, Weatherall DJ. K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature 280(5718), 164-165 (1979). (Pubitemid 9221749)
27. Wanda PE, Walker MM. Hemoglobin induction by Ara-C in human erythroleukemic cells (K562) is cell-cycle dependent. Leuk. Res. 13(8), 683-688 (1989). (Pubitemid 19241895)
28. Witt O, Sand K, Pekrun A. Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 95(7), 2391-2396 (2000). (Pubitemid 30167741)
29. Lampronti I, Bianchi N, Borgatti M, Fibach E, Prus E, Gambari R. Accumulation of g-globin mRNA in human erythroid cells treated with angelicin. Eur. J. Haematol. 71(3), 189-195 (2003). (Pubitemid 37082842)
30. Bianchi N, Osti F, Rutigliano C et al. The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells. Br. J. Haematol. 104(2), 258-265 (1999). (Pubitemid 29083331)
31. Bianchi N, Chiarabelli C, Borgatti M, Mischiati C, Fibach E, Gambari R. Accumulation of g-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine. Br. J. Haematol. 113(4), 951-961 (2001). (Pubitemid 32634764)
32. Bianchi N, Ongaro F, Chiarabelli C et al. Induction of erythroid differentiation of human K562 cells by cisplatin analogs. Biochem. Pharmacol. 60(1), 31-40 (2000). (Pubitemid 30243082)
33. Alter BP, Goff SC. Electrophoretic separation of human embryonic globin demonstrates 'a-thalassemia? in human leukemia cell line K562. Biochem. Biophys. Res. Commun. 94(3), 843-848 (1980). (Pubitemid 10015786)
34. Pope SH, Fibach E, Sun J, Chin K, Rodgers GP. Two-phase liquid culture system models normal human adult erythropoiesis at the molecular level. Eur. J. Haematol. 64(5), 292-303 (2000). (Pubitemid 30307701)
35. Fibach E, Bianchi N, Borgatti M, Prus E, Gambari R. Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Blood 102, 1276-1281 (2003). (Pubitemid 36988033)
36. Liakopoulou E, Li Q, Stamatoyannopoulos G. Induction of fetal hemoglobin by propionic and butyric acid derivatives: correlations between chemical structure and potency of Hb F induction. Blood Cells Mol. Dis. 29(1), 48-56 (2002).
37. Fibach E, Kollia P, Schechter AN, Noguchi CT, Rodgers GP. Hemin-induced acceleration of hemoglobin production in immature cultured erythroid cells: preferential enhancement of fetal hemoglobin. Blood 85(10), 2967-2974 (2005).
38. Amoyal I, Fibach E. Hemoglobin switch in the newborn: a flow cytometry analysis Neonatology 1, 61-68 (2007). (Pubitemid 46141202)
39. Johnson J, Hunter R, McElveen R, Qian XH, Baliga BS, Pace BS. Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid. Cell Mol. Biol. 51(2), 229-238 (2005). (Pubitemid 43086297)
40. Rhodes J, Hagen A, Hsu K et al. Interplay of pu.1 and GATA1 determines myelo-erythroid progenitor cell fate in zebrafish. Dev. Cell 8(1), 97-108 (2005). (Pubitemid 40058009)
41. Galloway JL, Wingert RA, Thisse C, Thisse B, Zon LI. Loss of GATA1 but not GATA2 converts erythropoiesis to myelopoiesis in zebrafish embryos. Dev. Cell 8(1), 109-116 (2005). (Pubitemid 40058010)
42. Schier AF, Giraldez AJ. microRNA function and mechanism: insights from zebra fish. Cold Spring Harb. Symp. Quant. Biol. 71, 195-203 (2006).
43. Dong M, Fu YF, Du TT et al. Heritable and lineage-specific gene knockdown in zebrafish embryo. PLoS ONE 4(7), e6125 (2009).
44. Grabher C, Payne EM, Johnston AB et al. Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. Leukemia 25(3), 506-514 (2011).
45. Dore LC, Amigo JD, Dos Santos CO et al. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc. Natl Acad. Sci. USA 105(9), 3333-3338 (2008).
46. Du TT, Fu YF, Dong M et al. Experimental validation and complexity of miRNA-mRNA target interaction during zebrafish primitive erythropoiesis. Biochem. Biophys. Res. Commun. 381(4), 688-693 (2009).
47. Pase L, Layton JE, Kloosterman WP, Carradice D, Waterhouse PM, Lieschke GJ. miR-451 regulates zebrafish erythroid maturation in vivo via its target GATA2. Blood 113(8), 1794-1804 (2009).
48. Yu D, dos Santos CO, Zhao G et al. miR-451 protects against erythroid oxidant stress by repressing 14-3-3z. Genes Dev. 24(15), 1620-1633 (2010).
49. Fu YF, Du TT, Dong M et al. Mir-144 selectively regulates embryonic a-hemoglobin synthesis during primitive erythropoiesis. Blood 113(6), 1340-1349 (2009).
50. Kosaka N, Sugiura K, Yamamoto Y et al. Identification of erythropoietin-induced microRNAs in haematopoietic cells during erythroid differentiation. Br. J. Haematol. 142, 293-300 (2008). (Pubitemid 351987314)
51. Sankaran VG, Menne TF, Šćepanović D, et al. microRNA-15a and -16-1 act via Myb to elevate fetal hemoglobin expression in human trisomy 13. Proc. Natl Acad. Sci. USA 108(4), 1519-1524 (2011).
52. Gabbianelli M, Testa U, Morsilli O et al. Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex. Haematologica 95(8), 1253-1260 (2010).
53. Felli N, Pedini F, Romania P et al. microRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 94(4), 479-486 (2009).
54. Zhang L, Flygare J, Wong P, Lim B, Lodish HF. miR-191 regulates mouse erythroblast enucleation by down-regulating Riok3 and Mxi1. Genes Dev. 25(2), 119-124 (2011).
55. Svasti S, Masaki S, Penglong T et al. Expression of microRNA-451 in normal and thalassemic erythropoiesis. Ann. Hematol. 89(10), 953-958 (2010).
56. Felli N, Fontana L, Pelosi E et al. microRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl Acad. Sci. USA 102, 8081-8086 (2005).
57. Choong ML, Yang HH, McNiece I. microRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp. Hematol. 35, 551-564 (2007). (Pubitemid 46427958)
58. Georgantas RW 3rd, Hildreth R, Morisot S et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl Acad. Sci. USA 104, 2750-2755 (2007). (Pubitemid 46327951)
59. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M. A microRNA component of the hypoxic response. Cell Death Differ. 15, 667-671 (2008). (Pubitemid 351405070)
60. Fasanaro P, D?Alessandra Y, Di Stefano V et al. microRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 283, 15878-15883 (2008).
61. Rogers HM, Yu X, Wen J, Smith R, Fibach E, Noguch CT. Hypoxia alters progression of the erythroid program. Exp. Hematol. 36(1), 17-27 (2008). (Pubitemid 350266966)
62. Alter BP. Fetal erythropoiesis in stress hematopoiesis. Exp. Hematol. 7, 200-209 (1979).
63. Dixit A, Chatterjee TC, Mishra P et al. Hydroxyurea in thalassemia intermedia - a promising therapy. Ann. Hematol. 84(7), 441-446 (2005). (Pubitemid 40867920)
64. Watanapokasin Y, Chuncharunee S, Sanmund D et al. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in b-thalassemia/hemoglobin E patients. Exp. Hematol. 33(12), 1486-1492 (2005). (Pubitemid 41773849)
65. Xu XS, Hong X, Wang G. Induction of endogenous g-globin gene expression with decoy oligonucleotide targeting Oct-1 transcription factor consensus sequence. J. Hematol. Oncol. 2, 15 (2009).
66. Jiang J, Best S, Menzel S et al. cMyb is involved in the regulation of fetal hemoglobin production in adults. Blood 108(3), 1077-1083 (2006). (Pubitemid 44154648)
67. Sankaran VG, Xu J, Orkin SH. Transcriptional silencing of fetal hemoglobin by BCL11A. Ann. NY Acad. Sci. 1202, 64-68 (2010).
68. Satta S, Perseu L, Moi P et al. Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin. Haematologica 96(5), 767-770 (2011).
69. Zhou D, Liu K, Sun CW, Pawlik KM, Townes TM. KLF1 regulates BCL11A expression and g- to b-globin gene switching. Nat. Genet. 42(9), 742-744 (2010).
70. Borg J, Papadopoulos P, Georgitsi M et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat. Genet. 42(9), 801-805 (2010).
71. Woon Kim Y, Kim S, Geun Kim C, Kim A. The distinctive roles of erythroid specific activator GATA-1 and NF-E2 in transcription of the human fetal g-globin genes. Nucl. Acids Res. 39(16), 6944-6955 (2011).
72. Yao X, Kodeboyina S, Liu L et al. Role of STAT3 and GATA-1 interactions in g-globin gene expression. Exp. Hematol. 37(8), 889-900 (2009).
73. Bauer DE, Orkin SH. Update on fetal hemoglobin gene regulation in hemoglobinopathies. Curr. Opin. Pediatr. 23(1), 1-8 (2011).
74. Sankaran VG, Nathan DG. Reversing the hemoglobin switch. N. Engl. J. Med. 363(23), 2258-2260 (2010).
75. Ji P, Yeh V, Ramirez T, Murata-Hori M, Lodish HF. Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts. Haematologica 95(12), 2013-2021 (2010).
76. Mack GS. MicroRNA gets down to business. Nat. Biotechnol. 25(6), 631-638 (2007). (Pubitemid 46897194)
77. Wilber A, Hargrove PW, Kim YS et al. Therapeutic levels of fetal hemoglobin in erythroid progeny of b-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer. Blood 117(10), 2817-2826 (2011).
78. Watanapokasin R, Sanmund D, Winichagoon P, Muta K, Fucharoen S. Hydroxyurea responses and fetal hemoglobin induction in b-thalassemia/HbE patients? peripheral blood erythroid cell culture. Ann. Hematol. 85(3), 164-169 (2006). (Pubitemid 43174270)
79. Cao H. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors. Hematology 9(3), 223-233 (2004). (Pubitemid 38997062)
80. Zuo Z, Calin GA, de Paula HM et al. Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome. Blood 118(2), 413-415 (2011).
81. Corthals SL, Jongen-Lavrencic M, de Knegt Y et al. micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma. Leuk. Res. 34(5), 677-681 (2010).
82. Bhattacharya R, Nicoloso M, Arvizo R et al. miR-15a and miR-16 control Bmi-1 expression in ovarian cancer. Cancer Res. 69(23), 9090-9095 (2009).